Jundong Zhou

9PUBLICATIONS
15CO-AUTHORS
Cancer diagnosisCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Dec 23, 2025
Correction: TAB182 aggravates progression of esophageal squamous cell carcinoma by enhancing β-catenin nuclear translocation through FHL2 dependent manner.

Aidi Gao, Zhenzi Su, Zengfu Shang

|Aug 16, 2025
TRIM31 triggers colorectal carcinogenesis and progression by maintaining YBX1 protein stability through ubiquitination modification.

Xiaoqing Li, Ying Wu, Jiahao Guo

|Aug 20, 2024
Concurrent chemoradiotherapyof different radiation doses and different irradiation fields for locally advanced thoracic esophageal squamous cell carcinoma: A randomized, multicenter, phase III clinical trial.

Jian Zhang, Minghao Li, Kaixian Zhang

|Feb 24, 2024
DNA polymerase iota promotes EMT and metastasis of esophageal squamous cell carcinoma by interacting with USP7 to stabilize HIF-1α.

Aidi Gao, Mingxia Zhang, Shuang Qi Zhu

|Aug 09, 2023
Polymerase iota (POLI) confers radioresistance of esophageal squamous cell carcinoma by regulating RAD51 stability and facilitating homologous recombination.

Xiaoqing Li, Dexuan Gao, Fei Shen

|Apr 14, 2023
Correction: TAB182 aggravates progression of esophageal squamous cell carcinoma by enhancing β-catenin nuclear translocation through FHL2 dependent manner.

Aidi Gao, Zhenzi Su, Zengfu Shang

Pageof 2

Frequent Collaborators

4 joint publications

Zengfu Shang

4 joint publications

Ming Sun

4 joint publications

Yue Zhou

1 joint publications

Zeng-Fu Shang